ATE464043T1 - Pharmazeutische zusammensetzung enthaltend l- arginin - Google Patents

Pharmazeutische zusammensetzung enthaltend l- arginin

Info

Publication number
ATE464043T1
ATE464043T1 AT02774591T AT02774591T ATE464043T1 AT E464043 T1 ATE464043 T1 AT E464043T1 AT 02774591 T AT02774591 T AT 02774591T AT 02774591 T AT02774591 T AT 02774591T AT E464043 T1 ATE464043 T1 AT E464043T1
Authority
AT
Austria
Prior art keywords
arginine
pharmaceutical composition
composition containing
pharmaceutically acceptable
solid form
Prior art date
Application number
AT02774591T
Other languages
English (en)
Inventor
Harald Schmidt
Kirstin Wingler
Georg Komesker
Original Assignee
Vasopharm Biotech Gmbh
Pascoe Pharm Praeparate Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasopharm Biotech Gmbh, Pascoe Pharm Praeparate Gmbh filed Critical Vasopharm Biotech Gmbh
Application granted granted Critical
Publication of ATE464043T1 publication Critical patent/ATE464043T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT02774591T 2002-08-22 2002-09-10 Pharmazeutische zusammensetzung enthaltend l- arginin ATE464043T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0209395 2002-08-22
PCT/EP2002/010147 WO2004017955A1 (en) 2002-08-22 2002-09-10 L-arginine containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE464043T1 true ATE464043T1 (de) 2010-04-15

Family

ID=31896810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774591T ATE464043T1 (de) 2002-08-22 2002-09-10 Pharmazeutische zusammensetzung enthaltend l- arginin

Country Status (3)

Country Link
AT (1) ATE464043T1 (de)
DE (1) DE60236025D1 (de)
WO (1) WO2004017955A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018620A2 (en) * 2003-08-26 2005-03-03 Cell Center Cologne Gmbh Use of nitric oxide synthase (nos) cofactor for the treatment of sexual dysfunction
KR20070005550A (ko) 2003-11-17 2007-01-10 바이오마린 파머수티컬 인크. 대사 장애 치료를 위한 조성물 및 방법
EP1964566A4 (de) * 2005-12-22 2009-01-07 Asubio Pharma Co Ltd Zubereitung mit verbesserter bioabsorption von sapropterin-hydrochlorid
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
CA2706516C (en) * 2008-02-08 2014-12-16 Colgate-Palmolive Company Cleaning compositions and methods
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9089573B2 (en) 2009-07-22 2015-07-28 University Of Massachusetts Methods and compositions to reduce oxidative stress
ES2811515T3 (es) 2010-12-29 2021-03-12 Strategic Science & Tech Llc Tratamiento de disfunción eréctil y otras indicaciones
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
AU2013315750B9 (en) 2012-09-11 2018-11-15 Coherus Biosciences, Inc. Correctly folded etanercept in high purity and excellent yield
EP4158353A1 (de) * 2020-05-25 2023-04-05 Universiteit Maastricht Verfahren zur diagnose und behandlung von essentieller primärer hypertonie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008516A1 (en) * 1996-08-30 1998-03-05 Suntory Limited Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
US6063432A (en) * 1998-05-19 2000-05-16 Cooke Pharma Arginine or lysine containing fruit healthbar formulation
DE60027415T2 (de) * 2000-06-16 2006-10-19 Rath, Matthias, Dr.med. Zusammensetzung für die Verhinderung der Glattmuskelkrankheiten, die Ascorbat, Arginin und Magnesium enthält
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement

Also Published As

Publication number Publication date
DE60236025D1 (de) 2010-05-27
WO2004017955A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
MY147211A (en) Novel dihydropseudoerythromycin derivatives
DK1613304T3 (da) DPP-IV-inhibitorer
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
BRPI0410219A (pt) composições farmacêuticas de vareniclina
ATE528009T1 (de) Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
HUP0201083A2 (hu) Új atorvastatinsók és az azokat tartalmazó gyógyszerkészítmények
ATE388695T1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
GB0212410D0 (en) Organic compounds
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
TW200502235A (en) Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof
EP1219296A4 (de) Mittel zur hemmung der sebumproduktion
DE602004017514D1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
JP2004523567A5 (de)
AU2003256108A1 (en) Organic acid salt of amlodipine
EP1571144A4 (de) Hydroxyalkylierte cyclischediaminverbindung
ATE275577T1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
EA200600939A1 (ru) Фармацевтический препарат, содержащий габапентин
ATE356118T1 (de) Moexipril-magnesium enthaltende arzneimittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties